About Abtrace
Abtrace is a company based in London (United Kingdom) founded in 2018 by Umar Naeem Ahmad, Cristina Correia, and Helder Soares. Abtrace has raised $2.88 million across 3 funding rounds from investors including Gov.uk, EIT Health and Ganexa Capital. Abtrace offers products and services including Proactive Monitoring and Intelligent Recall. Abtrace operates in a competitive market with competitors including ApolloMed, Genomics, Assurecare, Patients Know Best and ZeOmega, among others.
- Headquarter London, United Kingdom
- Founders Umar Naeem Ahmad, Cristina Correia, Helder Soares
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
-$820.32 K (USD)0as on Aug 31, 2021
-
EBITDA
Not available
-
Total Equity Funding
$2.88 M (USD)
in 3 rounds
-
Latest Funding Round
$1.37 M (USD), Grant
Aug 26, 2021
-
Investors
Gov.uk
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abtrace
Abtrace offers a comprehensive portfolio of products and services, including Proactive Monitoring and Intelligent Recall.
Tool for managing chronic diseases and optimizing healthcare resources efficiently.
System that automates patient recalls and ensures timely monitoring actions.
Funding Insights of Abtrace
Abtrace has successfully raised a total of $2.88M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.37 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Abtrace
Abtrace has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, EIT Health and Ganexa Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ganexa Capital is engaged in investing in tech-focused startups.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage tech companies
|
Locked | Locked | Locked | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked |
Investor details for Abtrace
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abtrace
Investment portfolio details for Abtrace
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Abtrace
Detailed financials for Abtrace
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abtrace Comparisons
Peer comparison for Abtrace
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abtrace
Abtrace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ApolloMed, Genomics, Assurecare, Patients Know Best and ZeOmega, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health ecosystem participants are connected and provider support is integrated.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Digital population health management is provided for healthcare professionals.
|
|
| Locked | Locked | Locked |
Personal health records software is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Population health management software is provided to payers and providers.
|
|
| Locked | Locked | Locked |
Provider of a DIY data science platform for health organizations to explore data and get insights
|
Detailed competitors of Abtrace
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abtrace
Complete news archive for Abtrace
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abtrace
Abtrace was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Abtrace is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Umar Naeem Ahmad is the current CEO of Abtrace. They have also founded this company.
Abtrace is a funded company, having raised a total of $2.88M across 3 funding rounds to date.
Abtrace was founded in 2018 in London, United Kingdom, within the healthcare sector. An AI-based platform is offered to enable personalized care across large populations. The Proactive Monitoring tool is utilized to automate self-learning care systems and recall processes. Informed decisions are supported for clinicians, while patient outcomes are enhanced and overall healthcare efficiency is increased through these operations.
Abtrace's top competitors include HiLabs, Patients Know Best and Assurecare.
Abtrace offers Proactive Monitoring and Intelligent Recall.
Abtrace has 4 investors. Key investors include Gov.uk, EIT Health, Ganexa Capital, and Faber.